Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulised magnesium sulfate in severe asthma with persistent airflow limitation
2006-003417-41Phase 4Active
- Sponsor
- Frisius MC
- Start
- Aug 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in asthma comparing Nebulised magnesium sulfate with Placebo nebulisation (2 arms). Primary endpoint: Percent change in FEV1. Started Aug 2006; status: active.
02
Drugs
magnesium sulfate
03
Conditions
asthma
Beyond the preview
Go deeper on 2006-003417-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003417-41.